CUPR logo

Cuprina Holdings (Cayman) Limited Stock Price

NasdaqCM:CUPR Community·US$17.9m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

CUPR Share Price Performance

US$0.77
-3.38 (-81.45%)
US$0.77
-3.38 (-81.45%)
Price US$0.77

CUPR Community Narratives

There are no narratives available yet.

Snowflake Analysis

Moderate risk with weak fundamentals.

5 Risks
0 Rewards

Cuprina Holdings (Cayman) Limited Key Details

S$48.3k

Revenue

S$51.3k

Cost of Revenue

-S$3.0k

Gross Profit

S$1.6m

Other Expenses

-S$1.6m

Earnings

Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
-0.073
-6.26%
-3,229.52%
-131.0%
View Full Analysis

About CUPR

Founded
2019
Employees
14
CEO
Yong Qi Quek
WebsiteView website
www.cuprina.com.sg

Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds. The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products used as a biological debridement tool for chronic wounds under the MEDIFLY brand name. It is also developing collagen dressings, including sponges, particles, and hydrogels using bullfrog collagen derived from the valorization of abattoir waste; and products using medical leeches for wound treatment. The company was founded in 2019 and is based in Singapore. Cuprina Holdings (Cayman) Limited operates as a subsidiary of Cuprina Holding Pte. Ltd.

Recent CUPR News & Updates

Recent updates

No updates